PanopticAI adds FDA-cleared respiratory rate to its smartphone vital-signs platform
FDA clearance for contactless respiratory-rate measurement expands PanopticAI’s regulated digital-health platform, but restricted use, cloud dependence and uncertain reimbursement remain major commercial tests.